1. Home
  2. SLGL vs DIT Comparison

SLGL vs DIT Comparison

Compare SLGL & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • DIT
  • Stock Information
  • Founded
  • SLGL 1997
  • DIT 1981
  • Country
  • SLGL Israel
  • DIT United States
  • Employees
  • SLGL N/A
  • DIT N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • DIT Food Distributors
  • Sector
  • SLGL Health Care
  • DIT Consumer Discretionary
  • Exchange
  • SLGL Nasdaq
  • DIT Nasdaq
  • Market Cap
  • SLGL 69.1M
  • DIT 70.4M
  • IPO Year
  • SLGL 2018
  • DIT 1995
  • Fundamental
  • Price
  • SLGL $26.57
  • DIT $116.90
  • Analyst Decision
  • SLGL
  • DIT
  • Analyst Count
  • SLGL 0
  • DIT 0
  • Target Price
  • SLGL N/A
  • DIT N/A
  • AVG Volume (30 Days)
  • SLGL 32.9K
  • DIT 401.0
  • Earning Date
  • SLGL 11-14-2025
  • DIT 11-07-2025
  • Dividend Yield
  • SLGL N/A
  • DIT 0.86%
  • EPS Growth
  • SLGL N/A
  • DIT N/A
  • EPS
  • SLGL N/A
  • DIT 2.14
  • Revenue
  • SLGL $23,931,000.00
  • DIT $2,251,684,195.00
  • Revenue This Year
  • SLGL N/A
  • DIT N/A
  • Revenue Next Year
  • SLGL $31.17
  • DIT N/A
  • P/E Ratio
  • SLGL N/A
  • DIT $52.04
  • Revenue Growth
  • SLGL 264.86
  • DIT 7.64
  • 52 Week Low
  • SLGL $4.01
  • DIT $94.92
  • 52 Week High
  • SLGL $30.00
  • DIT $163.75
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 65.38
  • DIT 52.76
  • Support Level
  • SLGL $23.15
  • DIT $117.50
  • Resistance Level
  • SLGL $24.85
  • DIT $121.00
  • Average True Range (ATR)
  • SLGL 2.32
  • DIT 3.32
  • MACD
  • SLGL -0.41
  • DIT -0.37
  • Stochastic Oscillator
  • SLGL 61.43
  • DIT 58.33

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About DIT AMCON Distributing Company

Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.

Share on Social Networks: